Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen patient Access — Amgen Safety Net Foundation Free Medicine Provided in U.S. (Wholesale Acquisition Cost) ($B)
Amgen Sustainability Highlights Reports (2023–2025)
Latest, FY2025
1.70
Period ended Dec 31, 2025
Change on a year earlier
-32.0%
2.50 in FY2024
History
4 years
Since FY2022
Sources
1
Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Patient Access — Amgen Safety Net Foundation Free Medicine Provided in U.S. (Wholesale Acquisition Cost) ($B) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.70 | -32.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2024 | Dec 31, 2024 | 2.50 | 0.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2023 | Dec 31, 2023 | 2.50 | +13.6% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2022 | Dec 31, 2022 | 2.20 | – | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
Breakdown
What makes up patient access — amgen safety net foundation free medicine provided in u.s. (wholesale acquisition cost) ($b)
Cite this data
StockData. (2026). Amgen Patient Access — Amgen Safety Net Foundation Free Medicine Provided in U.S. (Wholesale Acquisition Cost) ($B), annual FY2022–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/esg_safety_net_val
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.